Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Feb;39(2):549–552. doi: 10.1128/aac.39.2.549

Effect of inflammation on intraocular penetration of intravenous ofloxacin in albino rabbits.

G Gatti 1, G Panozzo 1
PMCID: PMC162578  PMID: 7726531

Abstract

The effect of inflammation on the intraocular penetration of ofloxacin was studied in 20 albino rabbits (New Zealand White). Inflammation was induced in the left eye by inoculation of a suspension of 10(9) CFU of heat-killed Staphyloccus epidermidis per 0.1 ml of saline solution (0.9%) in the midvitreous cavity. The other eye was kept as a control. Twenty-four hours following inoculation, ofloxacin was administered in the marginal ear vein at a dose of 15 mg/kg over 20 min with an infusion pump. Animals were sacrificed at different times up to 24 h following drug administration. Ofloxacin levels were determined in aqueous humor, vitreous humor, and serum by a bioassay. Inflammation was scored on the basis of perilimbal and corneal reactions and vitreoretinal statuses. Inflammation had a relevant effect on intraocular penetration of ofloxacin, with levels in the ocular fluids of the inflamed eye markedly exceeding the ones of the control eye. In the uninflamed eye, the levels were rapidly decaying below assay sensitivity and were no longer detectable at approximately 5 h following drug administration while they were still detectable in both ocular fluids of the inflamed eye at 24 h. Ofloxacin levels in the ocular fluids of the inflamed eye were superior to the MIC for several of the bacteria which commonly cause endophthalmitis, including Staphylococcus epidermidis, Staphylococcus aureus, most members of the family Enterobacteriaceae, Haemophilus influenzae, and strains of Pseudomonas aeruginosa.

Full Text

The Full Text of this article is available as a PDF (192.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel R., Jr, Boyle G. L. Dissecting ocular tissue for intraocular drug studies. Invest Ophthalmol. 1976 Mar;15(3):216–219. [PubMed] [Google Scholar]
  2. Bennett J. V., Brodie J. L., Benner E. J., Kirby W. M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966 Mar;14(2):170–177. doi: 10.1128/am.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bohigian G. M., Olk R. J. Factors associated with a poor visual result in endophthalmitis. Am J Ophthalmol. 1986 Mar 15;101(3):332–341. doi: 10.1016/0002-9394(86)90829-9. [DOI] [PubMed] [Google Scholar]
  4. Borrmann L. R., Leopold I. H. The potential use of quinolones in future ocular antimicrobial therapy. Am J Ophthalmol. 1988 Aug 15;106(2):227–229. doi: 10.1016/0002-9394(88)90840-9. [DOI] [PubMed] [Google Scholar]
  5. Bron A., Talon D., Delbosc B., Estavoyer J. M., Kaya G., Royer J. La pénétration intracamérulaire de l'ofloxacine chez l'homme. J Fr Ophtalmol. 1987;10(6-7):443–446. [PubMed] [Google Scholar]
  6. Cochereau-Massin I., Bauchet J., Faurisson F., Vallois J. M., Lacombe P., Pocidalo J. J. Ocular kinetics of pefloxacin after intramuscular administration in albino and pigmented rabbits. Antimicrob Agents Chemother. 1991 Jun;35(6):1112–1115. doi: 10.1128/aac.35.6.1112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cochereau-Massin I., Bauchet J., Marrakchi-Benjaafar S., Saleh-Mghir A., Faurisson F., Vallois J. M., Vallee E., Pocidalo J. J. Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis. Antimicrob Agents Chemother. 1993 Apr;37(4):633–636. doi: 10.1128/aac.37.4.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Eichenbaum D. M., Jaffe N. S., Clayman H. M., Light D. S. Pars plana vitrectomy as a primary treatment for acute bacterial endophthalmitis. Am J Ophthalmol. 1978 Aug;86(2):167–171. doi: 10.1016/s0002-9394(14)76806-0. [DOI] [PubMed] [Google Scholar]
  9. Fisch A., Lafaix C., Salvanet A., Cherifi M., Meulemans A. Ofloxacin in human aqueous humour and lens. J Antimicrob Chemother. 1987 Sep;20(3):453–454. doi: 10.1093/jac/20.3.453. [DOI] [PubMed] [Google Scholar]
  10. Forster R. K., Abbott R. L., Gelender H. Management of infectious endophthalmitis. Ophthalmology. 1980 Apr;87(4):313–319. doi: 10.1016/s0161-6420(80)35241-x. [DOI] [PubMed] [Google Scholar]
  11. Fukuda M., Sasaki K. Intraocular dynamic mode differences of new quinolone antibacterial agents between pigmented and albino rabbit eyes. Lens Eye Toxic Res. 1989;6(1-2):339–351. [PubMed] [Google Scholar]
  12. Guay D. R., Opsahl J. A., McMahon F. G., Vargas R., Matzke G. R., Flor S. Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteers. Antimicrob Agents Chemother. 1992 Feb;36(2):308–312. doi: 10.1128/aac.36.2.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Keren G., Alhalel A., Bartov E., Kitzes-Cohen R., Rubinstein E., Segev S., Treister G. The intravitreal penetration of orally administered ciprofloxacin in humans. Invest Ophthalmol Vis Sci. 1991 Jul;32(8):2388–2392. [PubMed] [Google Scholar]
  14. Lode H., Höffken G., Olschewski P., Sievers B., Kirch A., Borner K., Koeppe P. Pharmacokinetics of ofloxacin after parenteral and oral administration. Antimicrob Agents Chemother. 1987 Sep;31(9):1338–1342. doi: 10.1128/aac.31.9.1338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Martin D. F., Ficker L. A., Aguilar H. A., Gardner S. K., Wilson L. A., Meredith T. A. Vitreous cefazolin levels after intravenous injection. Effects of inflammation, repeated antibiotic doses, and surgery. Arch Ophthalmol. 1990 Mar;108(3):411–414. doi: 10.1001/archopht.1990.01070050109043. [DOI] [PubMed] [Google Scholar]
  16. Monk J. P., Campoli-Richards D. M. Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1987 Apr;33(4):346–391. doi: 10.2165/00003495-198733040-00003. [DOI] [PubMed] [Google Scholar]
  17. Osato M. S., Jensen H. G., Trousdale M. D., Bosso J. A., Borrmann L. R., Frank J., Akers P. The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. Am J Ophthalmol. 1989 Oct 15;108(4):380–386. doi: 10.1016/s0002-9394(14)73305-7. [DOI] [PubMed] [Google Scholar]
  18. Phillips I., King A. Comparative activity of the 4-quinolones. Rev Infect Dis. 1988 Jan-Feb;10 (Suppl 1):S70–S76. doi: 10.1093/clinids/10.supplement_1.s70. [DOI] [PubMed] [Google Scholar]
  19. Shrader S. K., Band J. D., Lauter C. B., Murphy P. The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis. 1990 Jul;162(1):115–120. doi: 10.1093/infdis/162.1.115. [DOI] [PubMed] [Google Scholar]
  20. Skoutelis A. T., Gartaganis S. P., Chrysanthopoulos C. J., Beermann D., Papachristou C., Bassaris H. P. Aqueous humor penetration of ciprofloxacin in the human eye. Arch Ophthalmol. 1988 Mar;106(3):404–405. doi: 10.1001/archopht.1988.01060130430035. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES